NextPlat Corp (NXPL) reports a 66% increase in recurring revenue airtime contracts and strategic expansions, despite facing profit margin pressures and non-recurring expenses.

Discover OncoCyte's Q4 2024 progress with its cutting-edge kidney transplant test. Insights on FDA ambitions, market strategies & financial runway.

PAR Technology's transition to a subscription-based model and strategic acquisitions drive significant growth. Read why the ...

SINGAPORE, March 25, 2025 (GLOBE NEWSWIRE) -- BitFuFu Inc. ("BitFuFu” or the "Company”) (NASDAQ: FUFU), a global leader in ...

Joining us today are Oncocyte President and CEO, Josh Riggs; Chief Science Officer, Ekke Schutz; and CFO, Andrea James. We ...

Investors can consider stocks across software, hardware, and robotics.

BitFuFu Inc. ("BitFuFu" or the "Company") (NASDAQ: FUFU), a global leader in Bitcoin mining and comprehensive mining services, today announced its unaudited ...

The $1.4 billion figure means that Anthropic’s recent monthly revenue was around $116 million. According to The Information, which first reported news of Anthropic’s current revenue, Anthropic’s ARR ...

As competition intensifies and margins shrink, manufacturers that successfully transition to service-oriented models will ...

Integrators face new challenges, and adapting to market realities is pushing integrators to consider something new: Managed ...

For the quarter that ended on Jan. 31, SentinelOne reported adjusted earning per share of four cents, up from a loss of two ...

AI-powered search startup Perplexity is said to be in early talks to raise up to $1 billion in a new funding round valuing ...